A Study to Assess the Safety and Tolerability of SSS11 in Healthy Subjects.
Clinical trial NCT03388515 · UNKNOWN
Trial details
- NCT number
- NCT03388515
- Sponsor
- Shenyang Sunshine Pharmaceutical Co., LTD.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-09
- Primary completion
- 2019-07-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.